<ul><li>UK-based AI-driven drug discovery and precision medicine company Zephyr AI has raised USD 18.5 million in a seed funding round after emerging from stealth in November 2021. The round was led by Lerner Group Investments LLC and M-Cor Holdings with participation from AME Cloud Ventures, BoxGroup, and others.</ul>
The proceeds will be directed toward advancing its AI capabilities and growing its healthcare datasets. It is also pursuing industry partnerships to accelerate the use of its technology.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.